CURRICULUM VITAE Viviana Elizabeth Horigian, M.D. I....
Transcript of CURRICULUM VITAE Viviana Elizabeth Horigian, M.D. I....
1
CURRICULUM VITAE
Viviana Elizabeth Horigian, M.D.
1. Date: February, 2017
I. Personal
2. Name: Viviana Elizabeth Horigian, M.D.
3. Home Phone:
4. Office Phone: (305) 243-4305
5. Address:
6. Current Academic Rank: Associate Professor
6A. Current Track of Appointment: Educator Track
7. Primary Department: Public Health Sciences
8. Secondary or Joint Appointment: N/A
9. Citizenship: US Citizen
10. Visa Type: N/A
II. Higher Education
11. Institutional:
1993-1996 Specialty Degree in Psychiatry, School of Medicine, University of Buenos Aires
(Spanish: Universidad de Buenos Aires- UBA), Buenos Aires, Argentina1
1986-1991 M. D., with honors, School of Medicine, University of the Savior (Spanish:
Universidad del Salvador- USAL), Buenos Aires, Argentina
1981-1985 International Baccalaureate, St Catherine´s School, Buenos Aires, Argentina
12. Non-Institutional:
2000- 2001 Postgraduate in Clinical Research, Studies and Clinical Research Group
(Spanish: Grupo de Estudio e Investigación Clínica- GEDIC), Buenos Aires,
Argentina
1 Please note that in Argentina in addition to the 3 year residency program, a separate 3 year post graduate degree is required for a specialist in Psychiatry.
2
1997-1999 Postgraduate in Marital and Family Studies and Psychoanalysis, Graduate
School for Psychotherapy (Spanish: Escuela de Psicoterapia para Graduados)
Buenos Aires, Argentina
1996-1993 Residency in Psychiatry, Italian Hospital of Buenos Aires (Spanish: Hospital
Italiano de Buenos Aires), Department of Psychiatry, Buenos Aires, Argentina
1992-1991 Postgraduate Internship: (Rotation in Medicine) Italian Hospital of Buenos Aires
(Spanish: Hospital Italiano de Buenos Aires), Buenos Aires, Argentina.
(Psychiatry Rotation) Harbor- UCLA, Torrance, Los Angeles, CA
13. Certification and Licensure:
2013 Project Manager Professional- PMP
2004 USMLE-1 U.S. Medical Licensing Examination
USMLE-2 Clinical Knowledge U.S. Medical Licensing Examination
USMLE-2 Clinical Skills U.S. Medical Licensing Examination
2005 Educational Commission for Foreign Medical Graduates Certification-ECFMG
2001 EEG/ Neurofeedback Certificate Program, St. Paul, MN
2001 Biofeedback training, Professional Biofeedback Certificate Program, St Paul, MN
III. Experience
14. Academic:
2015-Present Associate Professor, Department of Public Health Sciences, University of
Miami School of Medicine, Miami, Florida
2008-2014 Research Assistant Professor, Center for Family Studies,
Department of Public Health Sciences, University of Miami School of Medicine,
Miami, Florida
2005-2007 Research Assistant Professor, Center for Family Studies, Department of
Psychiatry & Behavioral Sciences, University of Miami School of Medicine,
Miami, Florida.
2002-2005 Assistant Scientist, Center for Family Studies, Department of Psychiatry &
Behavioral Sciences, University of Miami Miller School of Medicine
1999-2001 Clinical Assistant Professor of Psychiatry, School of Medicine, University of
Buenos Aires, (Spanish: Universidad de Buenos Aires- UBA), Buenos Aires,
3
Argentina.
1989-1991 Teaching Assistant Student for Histology, Embryology Cytology and
Genetics, assigned by the Dean of the School of Medicine, University of the
Savior (Spanish: Universidad del Salvador- USAL) Buenos Aires, Argentina.
15. Hospital Appointments:
1999- 2001 Director of Smoking Cessation Program, Italian Hospital of Buenos Aires
(Spanish: Hospital Italiano de Buenos Aires), Department of Psychiatry,
Outpatient Clinic, Buenos Aires, Argentina.
1996-2001 Admission and Outpatient Diagnostic Evaluation Psychiatrist, Italian
Hospital of Buenos Aires (Spanish: Hospital Italiano de Buenos Aires),
Department of Psychiatry, Outpatient Clinic, Buenos Aires, Argentina.
1996-1999 Instructor and Resident in Chief, Residency Program in Psychiatry, Italian
Hospital of Buenos Aires (Spanish: Hospital Italiano de Buenos Aires),
Department of Psychiatry, Buenos Aires, Argentina.
16. Non- Academic:
2009-2008 Program consultant for To Life Center, Weight loss, Wellness and Lifestyle
Change, Miami, Florida.
2001-1999 Psychiatrist in Consultation at Rehabilitation and Surgery Clinic (Spanish:
Clínica de Rehabilitación y Cirugía -CIAREC) Buenos Aires, Argentina.
1987-1986 English Teacher for (2nd, 6th and 7th grade) Mekhitarista School of Buenos
Aires (Spanish: Colegio Mekhitarista de Buenos Aires) Buenos Aires, Argentina.
17. Military:
None
4
IV. Publications
18. Books and Monographs Published:
1. Horigian, V.E., & Szapocznik, J. Brief Strategic Family Therapy: Thirty-five years of
interplay among theory, research and practice in adolescent behavior problems and drug abuse.
In L.M. Scheier (Ed.), APA Handbook of Drug Prevention: Research, Intervention Strategies
and Practice, Washington, DC, US: American Psychological Association, pp 249-265, 2015.
2. Medina-Mora, ME., Noknoy, S., Cherpitel, C., Real, T., Pérez Velasco, R., Marín Navarrete, R.
Amador, N., Horigian, V.E. Trials of Interventions for People with Alcohol Use Disorders. In
G.Thornicroft & V. Patel (Ed.), Global Mental Health Trials, Oxford University Press, pp 179-
202, 2014.
3. Robbins, M.S., Horigian, V.E., Szapocznik, J., & Ucha, J. Treating Hispanic youth using brief
strategic family therapy. In J. R. Weisz & A. E. Kazdin (Eds.), Evidence-based psychotherapies
for children and adolescents (2nd ed.), New York: Guilford, pp 375-390, 2010.
4. Robbins, M.S., Szapocznik, J. & Horigian, V.E. Brief strategic family therapy for adolescents
with behavior problems. In J.H. Bray (Ed.), Handbook of Family Psychology, Wiley Blackwell,
United Kingdom, pp 416-430 2008.
5. Robbins, M.S., Horigian, V. E., & Szapocznik, J. Brief Strategic Family Therapy. In N.
Jainchill (Ed.), Understanding and Treating Adolescent Substance Use Disorders. Kingston,
New Jersey: Civic Research Institute, Inc., pp 10-23, 2007.
6. Horigian, V.E. Suarez-Morales, L., Robbins, M.S., Zarate, M., Mayorga, C.C., Mitrani, V.B.,
& Szapocznik, J. Brief Strategic Family Therapy for adolescents with behavior problems. In
J.L. Lebow (Ed.) Handbook of clinical family therapy, , Hoboken, NJ: Wiley. pp. 73-102, 2005.
7. Horigian, V.E. Psiquiatría Psicodinámica en la Práctica Clínica [Spanish Translation of the
book Psychodynamic psychiatry in clinical practice (3rd Ed., G. Gabbard, M.D., Ed.). Editorial
Médica Panamericana, Buenos Aires, Argentina. [Panamerican Medical Press], 2002.
19. Juried or Refereed Journal Articles or Exhibitions:
1. Horigian, V.E, Anderson AR, Szapocznik, J. Family Based Treatments for Adolescent
Substance Abuse Child Adolesc Psychiatr Clin N Am. Oct;25(4):603-28, 2016. doi:
10.1016/j.chc.2016.06.001 Impact Factor: 1.68
2. Marín-Navarrete R., Medina-Mora M.E., Horigian V.E., Salloum IM, Villalobos-Gallegos L,
Fernández-Mondragón J.Co-Occurring Disorders: A Challenge for Mexican Community-Based
Residential Care Facilities for Substance Use.J Dual Diagn. Jul-Dec;12(3-4):261-270, 2016.
Impact Factor : 1.180
5
3. Hatch-Maillette M, Wells EA, Doyle SR, Brigham GS, Daley D, DiCenzo J, Donovan D,
Garrett S, Horigian V.E., Jenkins L, Killeen T, Owens M, Perl HI. Predictors of 12-Step
Attendance and Participation for Individuals With Stimulant Use Disorders. Journal of
Substance Abuse Treatment. Sep;68:74-82, 2016. doi: 10.1016/j.jsat.2016.06.007. Impact
Factor : 2.46
4. Horigian, V. E., Espinal, P. S., Alonso, E., Verdeja, R. E., Duan, R., Usaga, I. M., ... Feaster,
D. J. (2016). Readiness and barriers to adopt evidence-based practices for substance abuse
treatment in Mexico. Salud Mental, 39(2), 77-84. doi: 10.17711/SM.0185-3325.2016.004
5. Horigian V.E., Anderson AR, Szapocznik J.Taking Brief Strategic Family Therapy from
Bench to Trench: Evidence Generation Across Translational Phases. Family Process.
Sep;55(3):529-42, 2016 doi: 10.1111/famp.12233. Impact Factor : 2.187
6. Jacobs P, Estrada YA, Tapia MI, Quevedo Terán AM, Condo Tamayo C, Albán García M,
Valenzuela Triviño GM, Pantin H, Velazquez MR, Horigian V.E., Alonso E, Prado G.
Familias Unidas for high risk adolescents: Study design of a cultural adaptation and
randomized controlled trial of a U.S. drug and sexual risk behavior intervention in Ecuador.
Contemporary Clinical Trials. Mar; 47:244-53, 2016. doi: 10.1016/j.cct.2016.01.014. Impact
factor: 2.052
7. Peltzer K., Prado G., Horigian V.E., Weiss S., Cook R., Sifunda S., & Jones D. Prevention of
mother-to-child transmission (PMTCT) implementation in rural community health centres in
Mpumalanga province, South Africa. Journal of Psychology in Africa Vol. 26, Iss. 5, 2016
Impact factor: 0.207
8. Horigian, V. E., Feaster, D. J., Robbins, M., Brincks, A., Ucha, J., Rohrbaugh, M., Shoham,
V., Bachrach, K., Miller, M., Burlew, K., Hodgkins, C. C., Carrion, I., Silverstein, M.,
Werstlein, R., & Szapocznik, J. A cross-sectional assessment of the long-term effects of Brief
Strategic Family Therapy for adolescent substance use. American Journal on Addictions
24(7):637-45, 2015. Impact factor:1:929
9. Horigian, V. E., Marín-Navarrete, R., Verdeja, R., Alonso, E., Pérez, M. A., Berlanga, C.,
Mondragon, J. F., Medina-Mora, M. E., & Szapocznik, J. Technology transfer for the
implementation of a clinical trials network of mental health and substance abuse in Mexico. -.
Revista Panam Salud Publica. 38(3):233-42, 2015. Impact factor: 0.85
10. Horigian, V. E., Feaster, D. J., Brincks, A., Robbins, M. S., Perez, M. A., & Szapocznik, J.
The effects of Brief Strategic Family Therapy (BSFT) on parent substance use and the
association between parent and adolescent substance use. Addictive Behaviors, 42, 44-50, 2015.
Impact Factor: 2.44
11. Kyle, T. L., Horigian, V. E., Tross, S., Gruber, V. A., Pereyra, M., Mandler, R. N., . . . Metsch,
L. R. Uptake of HIV testing in substance use disorder treatment programs that offer on-site
testing. AIDS and Behavior, 536-542, 2014–Impact Factor: 3.49
6
12. Marín Navarrete, R., Templos Nunez, L., Eloisa Hernandez, A., Villalobos- Gallegos, L.,
Verdeja, R.E., Alonso, E., Feaster, D.J. Horigian, V.E. Characteristics of a Treatment-Seeking
Population in Outpatient Addiction Treatment Centers in Mexico, Substance Use and Misuse,
49(13), 1784-1794, 2014 - Impact Factor :1.226
13. Kiluk, B.D., Dreifuss, J.A., Weiss, R.D., Horigian, V.E., & Carroll, K.M. Psychometric
properties of a Spanish-language version of the Short Inventory of Problems Psychology of
Addictive Behaviors, 27 (3):893-900, 2013.
14. Stoutenberg M., Lee D.C., Sui X., Hooker S., Horigian,V.E., Perrino T. & Blair S. Prospective
Study of Alcohol Consumption and the Incidence of Metabolic Syndrome in U.S. Men. British
Journal of Nutrition, 110(5):901-910, 2013.
15. Winhusen, T., Somoza, E., Lewis, D., Kropp, F., Horigian, V.E., & Adinoff, B. Frontal
Systems Deficits in Stimulant-Dependent Patients: Evidence of Pre-illness Dysfunction and
Relationship to Treatment Response. Drug and Alcohol Dependence, 127(1-3):94-100, 2012.
16. Horigian, V.E., Weems, C.F., Robbins, M.S., Feaster, D.J., Ucha, J., Miller, M., & Werstlein,
R. Reductions in Anxiety and Depression Symptoms in youth receiving substance use
treatment. American Journal on Addictions, 22(4) 329-337, 2013.
17. Warden, D., Trivedi, M.H., Greer, T.G., Nunez, E., Granneman, B.D., Horigian, V.E.,
Somoza, E., Ring, K., Kyle, T., & Szapocznik, J. Rationale and methods for site selection for a
trial using a novel intervention to treat stimulant abuse. Contemporary Clinical Trials, 33(1)
29-37, 2012.
18. Robbins, M.S., Feaster, D.J., Horigian, V.E., Rohrbaugh, M., Shoham, V., Bachrach, K.,
Miller, M., Burlew, K., Hodgkins, C., Carrion, I., VanDeMark, N., Schindler, E., Werstlein, R.,
& Szapocznik, J. Brief Strategic Family Therapy versus Treatment as Usual: Results of a Multi-
Site Randomized Trial for Substance Using Adolescent. Journal of Consulting and Clinical
Psychology, 79(6), 713-727, 2011.
19. Robbins, M.S., Feaster, D.J., Horigian, V.E., Puccinelli, M., Henderson, C., & Szapocznik, J.
Therapist Adherence in Brief Strategic Family Therapy for Adolescent Drug Abusers. Journal
of Consulting and Clinical Psychology, 79, 43–53, 2011.
20. Weems, C. F., Feaster, D. J., Horigian, V.E., & Robbins, M. S. Parent and child agreement on
anxiety disorder symptoms using the DISC predictive scales. Assessment,; 18, 213–216, 2011.
21. Robbins, M.S., Alonso, E., Horigian, V.E., Bachrach, K., Carrión, I.S., Hodgkins, C.C.,
Miller, M., Schindler, E., Van DeMark, N., Henderson C., & Szapocznik, J. Transporting
Clinical Research to Community Settings: Implementing Brief Strategic Family Therapy
(BSFT) in Community Substance Abuse Treatment. Addiction Science & Clinical Practice,
5(2), 59-61, 2010.
22. Horigian, V.E., Robbins, M.S., Dominguez, R., Ucha, J., & Rosa, C.L. Principles for defining
adverse events in behavioral intervention research: Lessons from a family focused adolescent
drug abuse trial. Clinical Trials, 7, 58–68, 2010.
7
23. Feaster, D.J., Robbins, M.S., Henderson, C., Horigian, V.E., Puccinelli, M.J.,Burlew, K.,
Szapocznik, J. Equivalence of family functioning and externalizing in adolescent substance
users of different race/ethnicity. Journal of Substance Abuse Treatment, 38, S1:S113-S124,
2010.
24. Robbins, M., Szapocznik, J., Horigian, V. E., Feaster, D. , Puccinelli, M, Jacobs, P., Burlew,
K., Werstlein, R., Bachrach, K., & Brigham, G. Brief Strategic Family Therapy for Adolescent
Drug Abusers: A Multi-Site Effectiveness Study. Contemporary Clinical Trials 30, 269–278,
2009.
25. Robbins, M.S., Horigian, V.E., & Szapocznik, J. Brief Strategic Family Therapy: Ein
empirisch überprüfter ansatz zur reduction von Verhaltensproblemen jugendlicher [Brief
Strategic Family Therapy: An empirically-validated intervention for reducing adolescent
behavior problems]. Prax. Kinderpsychol. Kinderspcyhiat [Practice of Child Psychology and
Child Psychiatry], 57, 381-400, 2008.
26. Robbins, M.S., Horigian, V.E., & Szapocznik, J. Brief Strategic Family Therapy: An
Empirically Validated Family Therapy for adolescents with Disruptive Behavior. Journal of
Brief, Systemic, and Strategic Therapies, 1 (1), 39-62, 2007.
27. Horigian, V.E., Lage, O.G., & Szapocznik, J. Cultural differences in adolescent drug abuse.
Adolescent Medicine Clinics [Invited, Special issue, on Substance Abuse Among Adolescents].
17, 469-498. 2006.
28. Horigian, V.E., Robbins, M.S., & Szapocznik, J. Brief Strategic Family Therapy. Brief
Strategic and Systemic Therapy: European Review [inaugural issue], 1, 251-271, 2004.
29. Feaster, D.J., Robbins, M.S. Horigian, V.E., & Szapocznik, J. Statistical issues in multi-site
effectiveness trials: The Case of Brief Strategic Family Therapy for adolescent drug abuse
treatment. Clinical Trials, 1, 428-439, 2004.
30. Horigian, V.E. “Sexo: aspectos biológicos de una variable compleja” [Sex: Biological aspects
of a complex variable] Vertex. Revista Argentina de Psiquiatría [Vertex. Argentine Journal of
Psychiatry], XI, 189-194, 2000.
31. Horigian, V.E. “Psicosis anfetamínica, actualización bibliográfica y presentación de un caso
clínico” [Amphetamine induced Psychoses, research update and case presentation.]. Clepios,
Una Revista Para Residentes de Salud Mental [Clepios: A Journal for Mental Health
Residents], III, (3), 102-105, 1997.
20. Other Works, Publications and Abstracts:
1. Feaster, D.J., Robbins, M.S., Horigian, V.E., & Szapocznik, J. Brief Strategic Family Therapy:
Statistical design of a multi-site effectiveness trial for adolescent drug abuse treatment.
Controlled Clinical Trials, 24, 43S-2405. [Abstracts of Symposium Presentations at the Annual
Meeting of the Society for Prevention Research: “Research to Policy”]. Washington, D.C.,
2003.
8
2. Horigian, V.E., Espinal-Nunez, P.S., Feaster, D.J., Alonso, E., Verdeja, R.E., Usaga, I., Perez,
A. & Marin-Navarrete, R. (2014). Readiness and barriers to adopt evidence-based practices for
substance abuse treatment in Mexico. Alcohol and Alcoholism Vol. 49, No. S1, pp. i1–i69,
2014.
3. Horigian, V. E., Feaster, D. J., Robbins, M. S., Brincks, A., Perez, M. A., & Szapocznik, J.
(2014). Long-term effects of Brief Strategic Family Therapy for adolescent substance users
[Abstract]. Drug and Alcohol Dependence, 140(0),02.265, 2014.
21. Other Works Accepted for Publication:
V. Professional
22. Funded Research Performed:
Title: Technology Transfer for the Implementation of Randomized Clinical Trials with the
NIDA CTN Standards at the National Institutes of Psychiatry in Mexico
Grant: # S-INLEC11GR020
Funding Agency: US Department of State
Principal Investigator: Viviana E. Horigian
Total: $844,689 Dates: 2011-2014
Title: Implementing Comprehensive PMTCT & HIV Prevention for South African Couples –
Collaboration for Implementation Science (Admin Supp)
Grant: #R01HD078187
Funding Agency: National Institute of Health/ PEPFAR
Principal Investigator: Deborah Jones
Role: Investigator Responsible for delivering training in implementation science
Total: $321,861. Dates: 2014-2015
Title: Florida Node Alliance of the National Institute on Drug Abuse Clinical Trials Network.
Grant: # U10-DA13720
Funding agency: National Institutes on Drug Abuse (NIDA)
Principal Investigator: Dr. Jose Szapocznik – Dr. Lisa Metsch
Role: Executive Director since 2013, Project Director 2010- 2013 , Node Coordinator 2006-
2010)
Total: $25,500,500 (infrastructure only) Dates: 2000-2020
Participation in Protocols implemented in the Florida Node Alliance
Title: CTN 0074: Primary Care Opioid Use Disorders Treatment Trial (PROUD)
Grant: # U10-DA13720
9
Funding agency: National Institutes on Drug Abuse (NIDA)
Role: University of Miami Principal Investigator
Total Supplement: $45,300 Dates: 2017
Participation in Protocols implemented in the Florida Node Alliance
Title: CTN 0051: Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
(X:BOT)
Grant: # U10-DA13720
Funding agency: National Institutes on Drug Abuse (NIDA)
Role: University of Miami Principal Investigator
Total Supplement: $940,776 Dates: 2014-2017
Title: CTN 0060: Computer-Facilitated Intervention for Adolescent Marijuana Use Prevention
(CAMP)
Funding agency: National Institutes on Drug Abuse (NIDA)
Grant: # U10-DA13720
Role: Investigator
Total Supplement: $740,564 Dates: 2015-2016
Title: CTN-0047: Screening, Motivational Assessment, Referral, and
Treatment in Emergency Departments (SMART-ED)
Funding agency: National Institutes on Drug Abuse (NIDA)
Grant: # U10-DA13720
Role: University of Miami Principal Investigator
Total supplement: $1,111,271 (Year 01) Dates: 2010- 2013
Title: Stimulant Reduction Intervention using Dosed Exercise (STRIDE)
Funding agency: National Institutes on Drug Abuse (NIDA)
Grant: # U10-DA13720
Role: University of Miami Principal Investigator
Total supplement: $3,300,000 Dates: 2009- 2013
Title: Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined
Individual-Group Intervention to Reduce Stimulant Use by Increasing 12-Step Involvement
Funding agency: National Institutes on Drug Abuse (NIDA)
Grant: # U10-DA13720
Role: University of Miami Principal Investigator
Total supplement: $1,000,000 Dates: 2008- 2011
Title: An evaluation of neurocognitive function, oxidative damage, and their association with
treatment outcomes in metamphetamine and cocaine abusers
Funding agency: National Institutes on Drug Abuse (NIDA)
Grant: # U10-DA13720
Role: University of Miami Principal Investigator
Total Supplement: $300,000 Dates: 2008- 2011
10
Title: Brief Strategic Family Therapy versus Treatment as Usual: Extended Follow-up for Drug
Using Adolescents.
Funding agency: National Institutes on Drug Abuse (NIDA)
Grant: # 1RC2DA028864
Funding Agency: National Institutes on Drug Abuse
Role: Co-Investigator
Total: $ 1,390,000 Dates: 2009-2012
Title: Brief Strategic Family Therapy for Adolescent Drug Abuse”
Principal Investigator: Dr. Jose Szapocznik
Funding agency: National Institutes on Drug Abuse (NIDA)
Role: National Project Coordinator (2002-2006), and Investigator (since 2007)
Total supplement: $12,000,000 (Florida Node Costs only- Lead and 5 sites)
Dates: 2001-2010
23. Editorial Responsibilities:
2014- Present- Editorial Board Member of Revista Salud Mental, Instituto Nacional de
Psiquiatría, Mexico.
24. Professional and Honorary Organizations:
Present- 2016 Academy of Medical Educators at the University of Miami
Present -2016 American Public Health Association
Present- 2009 National Hispanic Science Network
Present - 2012 Society of Clinical Trials
2011 Asociación de Conductas Adictivas y Patología Dual de
Iberoamérica
2001-1996 American Psychiatric Association (International Member)
2001-1996 Asociación de Psiquiatras Argentinos (APSA)
1992 New York Academy of Sciences
25. Honors and Awards:
2015 2015 NIDA international Award of Excellence in International Leadership
1992 Honor Diploma, School of Medicine, Universidad del Salvador, Buenos Aires,
Argentina
1985 Oratory Competition Award, National Council of Private Institutes (Spanish: Consejo
de Rectores de Institutos Privados) Buenos Aires, Argentina
1985 Essay Award by University of Belgrano (Spanish: Universidad de Belgrano) Buenos
Aires, Argentina
1985 Outstanding Student Award, St Catherine’s High School, Buenos Aires, Argentina.
26. Post-Doctoral Fellowships:
11
None
27. Other Professional Activities:
Present Member of the Youth Special Interest Group of the National Drug Abuse
Treatment Clinical trials Network
Present- 2016 Member of the Academic Affairs Section of the Association of Schools and
Programs of Public Health
Present-2015 Member of the Data Science Health Care Task Force of the National Drug
Abuse Treatment Clinical Trials Network
2014 Member of the Registry Special Interest Group of the National Drug Abuse
Treatment Clinical Trials Network.
2014 Member of the Adolescent Special Interest Group of the National Drug Abuse
Treatment Clinical Trials Network
Present-2009 Member of the Psychopharmacology Interest Group of the National Drug Abuse
Treatment Clinical Trials Network.
Present-2012 Member of the Design and Analyses Special Interest Group of the National Drug
Abuse Treatment Clinical Trials Network.
2001-1999 Member of the Anti- Tobacco Group Hospital Italiano (Grantahi)
2001-2000 Member of the Addiction Committee for Psychoanalitical Federation of Latin
America (Spanish: Federacion Psicoanalitica de Latinoamerica -FEPAL)
2001-1999 Member of the Addiction Committee, Asociación de Psiquiatras Argentinos
1999-1996 Member of the Epistemology Committee, Asociación de Psiquiatras Argentinos
Invited and Keynote Presentations
1. Robbins, M.S. & Horigian, V.E. Recruitment and retention challenges. Presented at the
National Institute on Drug Abuse’s Clinical Trials Network Meeting on Recruitment and
Retention in Clinical Trials. Rockville, Maryland, April, 2007
Presentations
1. Horigian, V.E., Muir, J., & Szapocznik, J. (2016). Parallel Processes in Family Therapy
Implementation Research: The Adventures of BSFT. In panel (Panel Chair: M. Rohrbaugh),
Think Systematically, Act Empirically: Varda Shoham’s Legacy for Psychotherapy Research.
Jerusalem: 2016 Annual Meeting of the Society for Psychotherapy Research.
12
2. Horigian, V.E., & Szapocznik, J. (2016). Insights from 35 years of research on Brief Strategic
Family Therapy. In panel (Panel Chair: Jay Lebow), 20/20 hindsight: Insights from programs of
family and child research over several decades. Jerusalem: 2016 Annual Meeting of the Society
for Psychotherapy Research.
3. Horigian VE, Perrino T, Kornfeld J. A Learning Collaboratory to develop student's core
professional and practice skills: An innovative approach to improving community health.
Presented at the Annual Meeting of the American Public Health Association, Chicago, IL,
November, 2015.
4. Villalobos-Gallegos, Marín-Navarrete, R., Feaster DJ Horigian VE Medina Mora ME Latent
Class Analysis of sexual risky behavior in patients with substance use disorders Profile of
Psychiatric Symptoms In A Sample of Patients With Co‐Occurring Disorders. Presented at the
Annual Meeting Of the National Institute of Psychiatry in Mexico, Mexico City, October, 2015.
5. Marín-Navarrete, R. Medina Mora, Horigian VE. Co-occuring Disorders In Mutual-Aid
Residential Centers For Addiction Care In Mexico: Results of a Cross-Sectional Study. Presented
during NIDA Clinical Trials Network (CTN) Steering Committee meeting, Gaithersburg, MD,
April, 2015.
6. Marin-Navarrete, R. Medina Mora ME, Horigian, VE Co-occuring disorders in residential
centers: A public health concern. Presented at the IV International Congress of Dual Disorders
Addictions and other Mental Disorders, Barcelona, April, 2015.
7. Horigian, V.E., Marin Navarrete, R.A, Medina- Mora, M.E., Szapocznik, J. Using Clinical
Trials to Develop and Implement Evidence Based Interventions in Mexico. Presented as part of
the panel on Implementation Science and Evidence Based Treatments in Latin America:
International Collaboration Challenges and Opportunities, NIDA International Forum. Phoenix,
AZ, June, 2015.
8. Szapocznik, J., & Horigian, V. Translating T1-T4 in a Behavioral Intervention: An Example
using the Brief Strategic Family Therapy® BSFT® Model for the Treatment of Adolescent
Drug Abuse. Presented as a poster the Annual Cane Search Symposium, University of Miami
Miller School of Medicine, Miami, FL, February, 2015.
9. Horigian, V.E., Espinal-Nunez, P.S., Feaster, D. J, Alonso, E., Verdeja, R., Usaga, I., Perez, A.
& Marin-Navarrete, R. Readiness and barriers to adopt evidence-based practices for
substance abuse treatment in Mexico. Presented at the Annual Cane Search Symposium,
University of Miami Miller School of Medicine, Miami, FL, February, 2015.
10. Szapocznik, J., & Horigian, V. Translating Behavioral Technologies to Practice & Back:
Interplay between Theory, Research & Practice: An Example using the Brief Strategic Family
Therapy® BSFT® Model for the Treatment of Adolescent Drug Abuse. Presented at the Second
Annual Cane Search Symposium to Showcase Scientific Collaboration, Promote Research
Resources, University of Miami Miller School of Medicine, Miami, FL, February, 2014.
11. Szapocznik, J., & Horigian, V. Translating Behavioral Technologies to Practice & Back:
Interplay between Theory, Research & Practice “An Example using the Brief Strategic Family
Therapy® BSFT® Model for the Treatment of Adolescent Drug Abuse”. Presented as invited
13
guest speaker at the “Susan Patrick Olson Lecture”, University of New Mexico, Albuquerque,
NM, May, 2014.
12. Horigian, V.E., Espinal-Nunez, P.S., Feaster, D. J, Alonso, E., Verdeja, R., Usaga, I., Perez, A.
& Marin-Navarrete, R. Readiness and barriers to adopt evidence-based practices for substance
abuse treatment in Mexico, presented as a poster at the 16th World Congress of Psychiatry
“Focusing on Access, quality and Humane Care”, Madrid, Spain, September, 2014.
13. Marín-Navarrete, R., Horigian, V.E, Fernandez Mondragon, J., Verdeja, R. E., Alonso,
Templos-Nuñez, L., Eloisa- Hernandez, A., Feaster, D.J., Sanchez- Huesca, R., De La Fuente,
A., Lima- Rodriguez., C. , Berlanga, C. , Medina- Mora, M.E. A multisite randomized
controlled trial of Motivational Enhancement Treatment in outpatient addiction care centers in
Mexico, presented as a poster at the 76th Annual Meeting of The College on Problems on Drug
Dependence, June, 2014.
14. Fernandez Mondragon, J., Horigian, V.E., Graue- Moreno, J., Alonso, E., Verdeja, R., Bucai –
Harari, L., De la Fuente, A., Berlanga, C., Marin Navarrete, R. “Safety reporting in
randomized clinical trials for behavioral interventions in Mexico”, presented as a poster at the
76th Annual meeting of The College on Problems on Drug Dependence, June, 2014.
15. Horigian, V.E, Marín-Navarrete, R., Verdeja, R.E., Alonso, E., Berlanga, C., Medina- Mora,
M.E., Szapocznik, J. “Technology Transfer for the Implementation of a Clinical Trials Network
for Substance Abuse and Mental Health in Mexico”, presented a poster at the 167th Annual
Meeting of the American Psychiatric Association, New York, May, 2014.
16. Horigian, V.E “Brief Strategic Family Therapy for Adolescent Drug Users: new results”
presented as part of a panel on advances in family therapy at the 15th International Conference
on Addictions organized by Centros de Integracion Juvenil, Cancun, December, 2013.
17. Marín-Navarrete, R., Horigian, V.E., Fernández-Mondragón, J., Verdeja, R.E., Alonso, E.,
Templos-Nuñez, L., Eliosa-Hernández, A., Feaster, D. Sánchez-Huesca, R., De la Fuente-
Martín, A., Lima-Rodríguez, C., Berlanga, C., Medina-Mora, ME. “Motivational
Enhancement Therapy to improve retention and treatment outcomes in Mexican substance
abuse treatment seekers: preliminary results”, presented as a poster at the 15th International
Conference organized by Centros de Integracion Juvenil, Cancun, December, 2013.
18. Fernández-Mondragón, J., Graue-Moreno, J., Bucay-Harari, L., Horigian,V.E., Alonso, E.,
Verdeja, RE, De La Fuente Martín, A., Berlanga, C., Marín-Navarrete, R. “Safety report and
adverse events in a behavioral clinical trial in Mexico”, presented as a poster at the 15th
International Conference organized by Centros de Integración Juvenil, Cancún, December,
2013.
19. Villalobos-Gallegos, L., Eliosa-Hernández, A., Pérez-López, A., Fernández-Mondragón, J.,
Templos-Nuñez, L., Larios-Chávez, L., Horigian, V.E., Marín-Navarrete, R. “Substance Use
variables and related consequences: Analyses from a Randomized Clinical Trial implemented
in Mexico” presented as a poster at the 15th International Conference organized by Centros de
Integración Juvenil, Cancun, December, 2013.
20. Templos-Nuñez, L., Jimena Cervera-Ballesteros, J., Eliosa-Hernández, A., Gómez-Valencia,
14
G., Galván-Sosa, D., Larios-Chávez, L., Luis Villalobos-Gallegos, L., Horigian, V.E., Marín-
Navarrete, R. “What happens behind doors?: Analyses of therapeutic elements in Treatment as
Usual sessions of a randomized clinical trial for addictions” presented as a poster at the 15th
International Conference organized by Centros de Integración Juvenil, Cancun, December,
2013.
21. Horigian, V.E. “A decade of experience of the National Drug Abuse Treatment Clinical Trials
Network: Bridging the Gap between Research and Practice to improve Drug abuse treatment.
Results from Behavioral Interventions” Presented as part the XXVII Research Annual Meeting
of the National Institute of Psychiatry, Mexico City, October, 2013.
22. Horigian, V.E. “Crossing borders and building bridges: Overview of a successful
international collaboration to improve substance abuse treatment research and practice in
Mexico”, presented as part of the panel on Technology Transfer for the Implementation of a
Clinical Trials Network on Drug Abuse and Mental Health in Mexico, National Hispanic
Science Network, Bethesda, October, 2013.
23. Horigian, V.E, Marín Navarrete, R., Medina Mora, M.E., Verdeja, R.E, Alonso, E., Berlanga
C., Sanchez- Huesca, R., Lima- Rodriguez, De la Fuente- Martin, A. “Development of a
Clinical Trials Network to test and disseminate evidence based practices to treat addiction and
mental disorders in Mexico” poster presented at The College of Problems on Drug
Dependence, San Diego, June, 2013.
24. Horigian V.E., Feaster D.J., Brincks A., Robbins M.S., Perez M.A. & Szapocznik J. “Long
term effects of Brief Strategic Family Therapy for Adolescent Drug Users”, poster presented at
The College on Problems on Drug Dependence, San Diego, June, 2013.
25. Killeen T., Korte J., Brigham G., Horigian V E., Carlini C, Donovan D. “Impact of a 12 Step
Facilitation Intervention on Tobacco Smoking Outcomes in Community Treatment Programs”,
poster presented at 75th Annual Meeting of The College on Problems on Drug Dependence, San
Diego, June, 2013.
26. Horigian, V. E., Feaster, D.J., Robbins M.S., Szapocznik, J. Brief Strategic Family Therapy.
presented at the Race and Ethnic Minorities Research Symposium, Washington, DC, April, 2013
27. Horigian, V.E., “A decade of experience of the National Drug Abuse Treatment Clinical Trials
Network: Bridging the Gap between Research and Practice to improve Drug abuse treatment.”
presentation delivered as part of plenary panel “The transference of Technology for Mental
Health Services”, at the Congreso Internacional de Centros de Integración Juvenil, Cancún,
December, 2012.
28. Horigian, V.E., “BSFT for adolescent drug abusers: Four decades of development, research
and clinical practice.” Presentation delivered as part of the panel on Family Therapy Congreso
Internacional de Centros de Integración Juvenil, Cancún, December, 2012.
29. Horigian, V.E., “Bridging the Gap between Research and Practice: A decade of experience of
the National Drug Abuse Treatment Clinical Trials Network”, presentation delivered as part of
the symposium titled Implementation Science: Translating the Efficacy of Drug Abuse
15
Treatment Research into the Community at the 12th International Congress of Behavioral
Medicine. Budapest, August 29th, 2012.
30. Horigian, V.E., Feaster, DJ, Duan, R, Perez, MA, Penn, P, Mandler, RN, Metsch, LR.
“Substance Use Treatment as a Preventive Strategy for Depression and Sexual Risk Behavior:
A Secondary Analysis of NIDA Clinical Trials Network Protocol CTN0032”, poster presented
at the XIX International AIDS Conference, Washington, DC, July 26th 2012.
31. Horigian, V.E. Treatment intervention Science and Clinical Trials in Drug Abuse. Workshop
at the Interdisciplinary Research Training Institute on Hispanic Drug Abuse, National Hispanic
Science Network Summer Institute, Los Angeles, CA, June 24th 2012.
32. Horigian, V.E., Feaster, D.J., Brincks, A., Robbins, M.S., Perez, M.A. & Szapocznik, J. The
effects of Brief Strategic Family Therapy (BSFT) on parent substance use and the association
between parent substance use and adolescent substance use. Poster presentation at the 74th
Annual Meeting of the College on Problems of Drug Dependence. Palm Springs, CA, June 9-
14th 2012.
33. Feaster, D.J., Horigian, V.E., Duan, R., Perez, M.A., Penn, P., Mandler, R.N., & Metsch, L.R.
“Substance Use Treatment as a Preventive Strategy for Depression and Sexual Risk Behavior:
A Secondary Analysis of NIDA Clinical Trials Network Protocol CTN0032.” Oral presentation
at the Society for Prevention Research Annual Meeting. Washington, DC May, 2012.
34. Horigian, V.E. “Participant barriers to compliance.” Presented as part of the panel, Dealing
with Treatment Compliance in Clinical Trials on Inherently Low-Compliant Populations: What
to do at the Design, Monitoring, and Analysis Stages (Invited Session 30), at the 33rd Annual
Meeting of the Society for Clinical Trials, Miami, FL, May 23rd 2012.
35. Horigian, V.E. “Spanish MET”. Presented as part of the symposium, Secondary Analyses of
MET/MI Studies, at the Spring NIDA Steering Committee Meeting. Atlanta, GA, April 18th
2012.
36. Horigian, V.E. Treatment intervention Science and Clinical Trials in Drug Abuse. Workshop
at the Interdisciplinary Research Training Institute on Hispanic Drug Abuse, National Hispanic
Science Network Summer Institute, Houston, TX, June 7th 2011.
37. Horigian, V.E. Robbins, M.S., Alonso, E., Bachrach, K., Carrión, I.S., Hodgkins, C.C., Miller,
M., Schindler, E., Van DeMark, N., Ucha, J., & Szapocznik, J. Transporting clinical research
into community settings: Implementing Brief Strategic Family Therapy in Community
Substance Abuse Treatment. Presented as a poster at the 138th American Public Health
Association Annual Meeting, Denver, CO, November 6-10th 2010.
38. Horigian, V.E., Robbins, M.S., Feaster, D.J. “Predictors of Outcomes in Brief Strategic Family
Therapy for Adolescent Drug Users.” Presented as part of the symposium, Beyond Main
Findings of NIDA Multi-Site Treatment Trials for Youth with Substance Use Disorders: What
Works and for Whom?, at the 57th American Academy of Child and Adolescent Psychiatry
Annual Meeting, New York, October 26-31, 2010.
16
39. Robbins, M.S., Feaster, D.J., & Horigian, V.E. “Adherence-outcome links in family therapy
with drug abusing adolescents.” Presented as part of the panel, Inside the Black Box:
Treatment Process for Youth Externalizing Behaviors, at the 118th Annual Meeting of the
American Psychological Association. San Diego, California, August, 2010.
40. Horigian, V.E. Treatment intervention Science and Clinical Trials in Drug Abuse. Workshop
at the Interdisciplinary Research Training Institute on Hispanic Drug Abuse, National Hispanic
Science Network Summer Institute, Houston, June 2010.
41. Horigian, V.E., Weems, C., Ucha-Vieta, J., Robbins, M.S. Psychiatric Comorbidity among
Youth Receiving Substance Abuse Treatment: Prevalence and the Effects of Intervention in
Reducing Symptoms and Incidence. Posted presented at the American Psychiatric Association,
Annual Meeting, San Francisco, May, 2009.
42. Robbins, M.S., Puccinelli, M.J., Horigian, V.E., & Ucha-Vieta, J. Results of a multi-site
effectiveness trial: Brief Strategic Family Therapy for adolescent drug abuse. Presented at the
117th annual convention of the American Psychological Association, Toronto, Canada, August,
2009.
43. Horigian, V.E, Szapocznik, J., Rosa, C., Jacobs, P. The Clinical Trials Network as a model for
implementing randomized clinical trials. Presented at the RECIA meeting, National Hispanic
memberScience Network, Bethesda, Maryland. , October, 2008.
44. Robbins, M.S., Szapocznik, J., Horigian, V.E., & Puccinelli, M. Brief strategic family therapy
for adolescent drug abusers. Presented at the Annual Meeting of the American Psychiatric
Association. Washington, D.C. May, 2008.
45. Robbins, M.S., Szapocznik, J., Feaster, D., Horigian, V.E., & Teszler, N. Measuring therapist
adherence in brief strategic family therapy. Paper presented as part of the panel on
Implementation Measurement with Evidence-Based Practices (Lisa Saldana, Chair) at the Joint
Meeting on Adolescent Treatment Effectiveness. Washington, D.C., April, 2007
46. Horigian, V.E. Overview of BSFT Protocol and the Lead Node’s Role in bringing the Protocol
to a Spanish Language Country. Presented at the NIDA Health Disparities Conference,
Atlanta, Georgia, October, 2005
47. Garcia de Amusquibar, A., Finkelsztein, C., Horigian, V.E., De Simone, C., Traumas de la
Infancia y trastornos de la Alimentación. Presented at the Salon del Consejo, Hopsital Italiano
(Paper selected within the 10 best scientific papers for the Premio Dr Jose Teszler a la
Investigación Clínica).
48. Robbins, M.S., & Horigian, V.E. Brief strategic family therapy: An empirically validated
intervention. Presented at the 53rd Annual Session of the University of Utah School on
Alcoholism and Other Drug Dependencies, Salt Lake City, Utah, June, 2004
49. Horigian, V.E. “Infarto de miocardio y depresión: Experiencia del servicio de psiquiatría del
Hospital Italiano” [Myocardial infarction and depression: Experience of the Department of
Psychiatry at the Italian Hospital of Buenos Aires.]. Symposium presented at the XVI
17
Argentine Conference on Psychiatry [“XVI Congreso Argentino de Psiquiatría”]. Sponsored
by the Argentine Psychiatric Association (APSA) [“Asociación de Psiquiatras , May, 2000
50. Horigian, V.E. “Género y psiquiatría: Perspectivas del Servicio de Psiquiatría del Hospital
Italiano de Buenos Aires” [Gender and psychiatry: Perspectives of the psychiatry service at the
Italian Hospital of Buenos Aires] Symposium presented at the XVI Argentine Conference on
Psychiatry [“XVI Congreso Argentino de Psiquiatría”]. Sponsored by the Argentine
Psychiatric Association (APSA) [“Asociación de Psiquiatras Argentinos/APSA”]. Mar del
Plata, Province of Buenos Aires, Argentina. , May, 2000
51. Horigian, V.E. “La razón de estar contigo” [The reason for being with you] Paper presented at
the First Meeting of Family and Couple Psychoanalysts [“Primer Encuentro de Psicoanalistas
de Familia y Pareja”]. Buenos Aires, Argentina, May 1999
52. Horigian, V.E. Gender and antipsychotic response. Poster presented at the XI World
Congress of Psychiatry. Sponsored by WPA, Hamburg, Germany, August, 1999
53. Horigian, V.E. Brief reactive psychoses in personality disorders. Poster presented at the XI
World Congress of Psychiatry. Sponsored by WPA, Hamburg, Germany, August, 1999
54. Horigian, V.E. “El suicidio a la luz de la cultura” [Suicide from a cultural perspective].
Symposium presented at the Regional Symposia of the Argentine Psychiatric Association
[“Simposio Regional de la Asociación Argentina de Psiquiatras”], Buenos Aires, Argentina.,
October, 1999
55. Horigian, V.E. “Criterios del servicio de psiquiatría del Hospital Italiano en internaciones
conflictivas”[Criteria of the Department of Psychiatry at the Italian Hospital of Buenos Aires
for conflictive hospitalizations ]. Symposium presented at the XV Argentine Conference on
Psychiatry. Sponsored by the Argentine Psychiatric Association (APSA) [“XV Congreso
Argentino de Psiquiatría, Asociación de Psiquiatras Argentinos/APSA]. Mar del Plata,
Provincia de Buenos Aires, Argentina., April, 1999
56. Horigian, V.E. “Tratamientos del paciente con trastornos de difícil abordaje” [Treatment of
patient with disorders of difficult approach] Symposium presented at the XV Argentine
Conference on Psychiatry. Sponsored by the Argentine Psychiatric Association (APSA) [“XV
Congreso Argentino de Psiquiatría, Asociación de Psiquiatras Argentinos/APSA]. Mar del
Plata, Provincia de Buenos Aires, Argentina., April, 1999
57. Horigian, V.E. “Suicido. Observaciones del servicio de psiquiatría del Hospital Italiano para el
tratamiento del paciente borderline grave” [Suicide: Observations of the Department of
Psychiatry at the Italian Hospital of Argentina on the treatment of seriously borderline
patients]. Symposium presented at the XV Argentine Conference on Psychiatry. Sponsored by
the Argentine Psychiatric Association (APSA) [“XV Congreso Argentino de Psiquiatría,
Asociación de Psiquiatras Argentinos/APSA]. Mar del Plata, Provincia de Buenos Aires,
Argentina, April, 1999
58. Horigian, V.E. “Fundamentos del Servicio de Psiquiatría del Hospital Italiano para el
tratamiento del paciente borderline grave” [Fundamentals of the Department of Psychiatry at
18
the Italian Hospital of Argentina for the treatment of the seriously borderline patient].
Symposium presented at the XIV Argentine Conference on Psychiatry. Sponsored by the
Argentine Psychiatric Association (APSA) [“XIV Congreso Argentino de Psiquiatría,
Asociación de Psiquiatras Argentinos/APSA]. Mar del Plata, Provincia de Buenos Aires,
Argentina., April, 1998
59. Horigian, V.E. “Experiencias del Hospital Italiano sobre descompensaciones agudas en los
trastornos de la personalidad” [Experience of the Italian Hospital of Argentina on acute
breakdowns in Borderline Personality Disorder.] Presented at the XIV Argentine Conference
on Psychiatry. Sponsored by the Argentine Psychiatric Association (APSA) [“XIV Congreso
Argentino de Psiquiatría, Asociación de Psiquiatras Argentinos/APSA]. Mar del Plata,
Provincia de Buenos Aires, Argentina., April 1998
60. Horigian, V.E, Perez Rivera, R., Trajterman, A., Canovi, A. Personality disorders in panic
attack. Poster presented as New Research at the 151st Annual Meeting of the American
Psychiatric Association, Toronto, Canada, June, 1998
61. Horigian, V.E. “Vigencia de la Psicosis Puerperal como entidad nosológica “[“Post partum
psychoses as nosological entity of current use ”] [Presented at the XII Argentine Conference
on Psychiatry. Sponsored by the Argentine Psychiatric Association (APSA) [“XII Congreso
Argentino de Psiquiatría, Asociación de Psiquiatras Argentinos/APSA]. San Miguel del
Tucumán, Provincia de Tucumán, Argentina, Octubre, 1996
62. Horigian, V.E. “Experiencia del Servicio de Psiquiatría del Hospital Italiano en la
internación del paciente borderline” [Experiences of the Psychiatric Service, Italian Hospital
of Buenos Aires, in the hospitalization of borderline patients]. Presented at the IV Argentine
Conference on Psychiatry. Sponsored by the Argentine Psychiatric Association (AAP) [“IV
Congreso Internacional de Psiquiatría, Asociación Argentina de Psiquiatras (AAP)]. Buenos
Aires, Argentina. October, 1996
VI. Teaching
28. Teaching Awards Received:
None
29. Teaching Specialization
29a. Courses Taught
June 2016 EPH 604: Clinical Trials. Summer Intensive for MPH & PhD candidates. Miami,
FL.
August 2016 EPH 584-04: Special Topics The Learning Collaboratory for MPH candidates,
Miami, Fl.
August 2015 EPH 584-04: Special Topics The Learning Collaboratory for MPH candidates,
19
Miami, Fl.
June 2015 EPH 604: Clinical Trials. Summer Intensive for MPH & PhD candidates. Miami,
FL.
August 2014 EPH 584-04: Special Topics The Learning Collaboratory for MPH candidates,
Miami, Fl.
June 2014 EPH 604: Clinical Trials. Summer Intensive for MPH & PhD candidates. Miami,
FL.
June 2013 EPH 604: Clinical Trials. Summer Intensive for MPH & PhD candidates. Miami,
FL.
June 2012 EPH 604: Clinical Trials. Summer Intensive for MPH & PhD candidates. Miami,
FL.
29b. Development of an Educational Program for the National Institute of Psychiatry in
Mexico: Training Modules Taught
January 2012 The Informed Consent Process. Webinar for researchers and practitioners of the
Mexican Clinical Trials Network, National Institutes of Psychiatry, Mexico.
January 2012 Assessing for Eligibility for the Motivational Enhancement Therapy Protocol.
Webinar for researchers at the National Institutes of Psychiatry, Mexico City.
October 2011 Protocol Specific Training for Motivational Enhancement Therapy at the as part
of the UM-National Institutes of Psychiatry collaboration project of Technology
Transfer for the Implementation of Randomized Clinical Trials, Mexico City.
June 2011 Development of Data Management Center and Systems, Mexico City.
April 2011 Clinical Trials Methodology and Management. Mexico City.
April 2011 Protocol Development: Adaptation of the CTN 0021 METS Randomized
Clinical Trials for implementation in Community Treatment Programs in
Mexico. Miami, FL.
February 2011 The National Drug Abuse Treatment Clinical Trials Network as a
model for transferring evidence practices to clinical settings. Methodology
of site selection for the creation of the CTN MEX. Mexico City, DF.
29.c Technology Transfer for the Implementation of the Familias Unidas Program for the
Universidad Católica Santiago de Guayaquil, Ecuador: Training Modules Taught:
July 2015 Fundamentals of Clinical Trials: Methods and Management, Santiago de Chile.
August 2014 Fundamentals of Clinical Trials: Methods and Management, Guayaquil, Ecuador
20
August 2014 Management of Clinical Trials, Miami, FL
29c. Lectures
April 2015 Invited Guest Lecturer on Improving Substance Abuse and Mental Health
Treatment Practices in Mexico: Implementing a National Drug Abuse Clinical
Trials Network for the course in Program Evaluation, taught at the Department
of Public Health Sciences, University of Miami. Instructor: Dr. Margaret Byrne.
September 2014. Implementation Science Workshop delivered together with Dr. Guillermo Prado
for researchers at the Human Science Research Council in South Africa.
October 2014 Invited Guest Lecture on “Mental and Substance Abuse Disorders, What do we
know and what can we do about it?” for the Course on Introduction to Public Health,
taught to MPH student at the Department of Public Health Sciences, University of
Miami. Instructor: Dr. Julie Kornfeld
July 2014 Invited Guest Lecture on “Mental and Substance Abuse Disorders, What do we
know and what can we do about it?” for the Course on Introduction to Public Health,
taught to MD/MPH student at the Department of Public Health Sciences, University
of Miami. Instructor: Dr. Julie Kornfeld
April 2014 Invited Guest Lecturer on Improving Substance Abuse and Mental Health
Treatment Practices in Mexico: Implementing a National Drug Abuse Clinical
Trials Network for the course in Program Evaluation, taught at the Department
of Public Health Sciences, University of Miami. Instructor: Dr. Margaret Byrne.
November 2013 Invited Guest Lecturer on Implementation of a Clinical Trials Network for
Mental Health and Substance Abuse in Mexico for the course on Introduction to
Disease Prevention, taught at the Department of Public Health Sciences,
University of Miami, Instructor: Dr. Guillermo Prado.
December 2009 EPH 584 Special Topics: An introduction to Clinical Trials. Miami, FL.
July 2007 Adverse events and Serious Adverse Events General Concepts and
Application in the Brief Strategic Family Therapy (BSFT) for Adolescent
Drug Abuse clinical trial, for members of the Clinical Trials Network,
National Institutes on Drug Abuse. (2 trainings)
November 2006 Adverse events and Serious Adverse Events General Concepts and
Application in the Brief Strategic Family Therapy (BSFT) for Adolescent
Drug Abuse clinical trial, for members of the Clinical Trials Network,
National Institutes on Drug Abuse. (2 trainings)
21
August 2006 Adverse events and Serious Adverse Events General Concepts and
Application in the Brief Strategic Family Therapy (BSFT) for Adolescent
Drug Abuse clinical trial, for members of the Clinical Trials Network,
National Institutes on Drug Abuse.
August 2006 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for
Adolescent Drug Abuse clinical trial, for members of the Clinical Trials
Network, National Institute on Drug Abuse.
May 2006 Adverse events and Serious Adverse Events General Concepts and
Application in the Brief Strategic Family Therapy (BSFT) for Adolescent
Drug Abuse clinical trial, for members of the Clinical Trials Network,
National Institutes on Drug Abuse. (2 trainings)
May 2006 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for
Adolescent Drug Abuse clinical trial, for members of the Clinical Trials
Network, National Institutes on Drug Abuse. (2 trainings)
April 2006 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for
Adolescent Drug Abuse clinical trial, for members of the Clinical Trials
Network, National Institutes on Drug Abuse.
April 2006 Adverse events and Serious Adverse Events General Concepts and
Application in the Brief Strategic Family Therapy (BSFT) for Adolescent Drug
Abuse clinical trial, for members of the Clinical Trials Network, National
Institutes on Drug Abuse.
March 2006 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for
Adolescent Drug Abuse clinical trial, for members of the Clinical Trials
Network, National Institutes on Drug Abuse.
March 2006 Adverse events and Serious Adverse Events General Concepts and
Application in the Brief Strategic Family Therapy (BSFT) for Adolescent
Drug Abuse clinical trial, for members of the Clinical Trials Network,
National Institutes on Drug Abuse.
March 2006 Good Clinical Practices: Consent and Progress Noting for Brief Strategic
Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for
members of the Clinical Trials Network, National Institutes on Drug
Abuse.
March 2006 Data Management and Clinical Data Collection for Brief Strategic
Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for
members of the Clinical Trials Network, National Institutes on Drug
Abuse.
February 2006 Adverse events and Serious Adverse Events General Concepts and
22
Application in the Brief Strategic Family Therapy (BSFT) for Adolescent
Drug Abuse clinical trial, for members of the Clinical Trials Network,
National Institutes on Drug Abuse.
February 2006 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for
Adolescent Drug Abuse clinical trial, for members of the Clinical Trials
Network, National Institutes on Drug Abuse.
November 2005 Data Management and Clinical Data Collection for Brief Strategic
Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for
members of the Clinical Trials Network, National Institutes on Drug
Abuse.
September 2005 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for
Adolescent Drug Abuse clinical trial, for members of the Clinical Trials
Network, National Institutes on Drug Abuse.
September 2005 Adverse events and Serious Adverse Events General Concepts and
Application in the Brief Strategic Family Therapy (BSFT) for Adolescent
Drug Abuse clinical trial, for members of the Clinical Trials Network,
National Institutes on Drug Abuse.
September 2005 Data Management and Clinical Data Collection for Brief Strategic
Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for
members of the Clinical Trials Network, National Institutes on Drug
Abuse.
September 2005 Recruitment, Retention and Follow up for Brief Strategic
Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for
members of the Clinical Trials Network, National Institutes on Drug
Abuse.
August 2005 Adverse events and Serious Adverse Events General Concepts and
Application in the Brief Strategic Family Therapy (BSFT) for Adolescent
Drug Abuse clinical trial, for members of the Clinical Trials Network,
National Institutes on Drug Abuse.
July 2005 Adverse events and Serious Adverse Events General Concepts and
Application in the Brief Strategic Family Therapy (BSFT) for Adolescent
Drug Abuse clinical trial, for members of the Clinical Trials Network,
National Institutes on Drug Abuse.
June 2005 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for
Adolescent Drug Abuse clinical trial, for members of the Clinical Trials
Network, National Institutes on Drug Abuse. (2 trainings)
May 2005 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for
Adolescent Drug Abuse clinical trial, for members of the Clinical Trials
23
Network, National Institutes on Drug Abuse.
May 2005 Adverse events and Serious Adverse Events General Concepts and
Application in the Brief Strategic Family Therapy (BSFT) for Adolescent
Drug Abuse clinical trial, for members of the Clinical Trials Network,
National Institutes on Drug Abuse.
May 2005 Data Management and Clinical Data Collection for Brief Strategic
Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for
members of the Clinical Trials Network, National Institutes on Drug
Abuse.
May 2005 Data Collection on Clinical Measures for Brief Strategic Family Therapy
(BSFT) for Adolescent Drug Abuse clinical trial, for Therapists of the
BSFT protocol, Clinical Trials Network, National Institutes on Drug
Abuse.
March 2005 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for
Adolescent Drug Abuse clinical trial, for members of the Clinical Trials
Network, National Institutes on Drug Abuse.
March 2005 Adverse events and Serious Adverse Events General Concepts and
Application in the Brief Strategic Family Therapy (BSFT) for Adolescent
Drug Abuse clinical trial, for members of the Clinical Trials Network,
National Institutes on Drug Abuse.
March 2005 Data Management and Clinical Data Collection for Brief Strategic
Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for
members of the Clinical Trials Network, National Institutes on Drug
Abuse.
March 2005 Data Collection on Clinical Measures for Brief Strategic Family Therapy
(BSFT) for Adolescent Drug Abuse clinical trial, for Therapists of the
BSFT protocol, Clinical Trials Network, National Institutes on Drug
Abuse.
March 2005 Recruitment, Retention and Follow up for Brief Strategic Family Therapy
(BSFT) for Adolescent Drug Abuse clinical trial, for members of the
Clinical Trials Network, National Institutes on Drug Abuse.
February 2005 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for
Adolescent Drug Abuse clinical trial, for members of the Clinical Trials
Network, National Institutes on Drug Abuse.
February 2005 Adverse events and Serious Adverse Events General Concepts and
Application in the Brief Strategic Family Therapy (BSFT) for Adolescent
Drug Abuse clinical trial, for members of the Clinical Trials Network,
National Institutes on Drug Abuse.
24
February 2005 Data Management and Clinical Data Collection for Brief Strategic
Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for
members of the Clinical Trials Network, National Institutes on Drug
Abuse.
February 2005 Data Collection on Clinical Measures for Brief Strategic Family Therapy
(BSFT) for Adolescent Drug Abuse clinical trial, for Therapists of the
BSFT protocol, Clinical Trials Network, National Institutes on Drug Abuse.
February 2005 Recruitment, Retention and Follow up for Brief Strategic
Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for
members of the Clinical Trials Network, National Institutes on Drug
Abuse.
November 2004 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for
Adolescent Drug Abuse clinical trial, for members of the Clinical Trials
Network, National Institutes on Drug Abuse.
November 2004 Adverse events and Serious Adverse Events General Concepts and
Application in the Brief Strategic Family Therapy (BSFT) for Adolescent
Drug Abuse clinical trial, for members of the Clinical Trials Network,
National Institutes on Drug Abuse.
November 2004 Data Management and Clinical Data Collection for Brief Strategic
Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for
members of the Clinical Trials Network, National Institutes on Drug
Abuse.
November 2004 Data Collection on Clinical Measures for Brief Strategic Family Therapy
(BSFT) for Adolescent Drug Abuse clinical trial, for Therapists of the BSFT
protocol, Clinical Trials Network, National Institutes on Drug Abuse.
November 2004 Recruitment, Retention and Follow up for Brief Strategic Family Therapy
(BSFT) for Adolescent Drug Abuse clinical trial, for members of the
Clinical Trials Network, National Institutes on Drug Abuse.
September 2004 Adverse events and Serious Adverse Events General Concepts and
Application in the Brief Strategic Family Therapy (BSFT) for Adolescent
Drug Abuse clinical trial, for members of the Clinical Trials Network,
National Institutes on Drug Abuse. (2 trainings)
September 2004 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for
Adolescent Drug Abuse clinical trial, for members of the Clinical Trials
Network, National Institutes on Drug Abuse.
29c. Other teaching activities: Mentoring
25
Present -August 2016 The Learning Collaboratory- Latin America
Capstone Advisor for MPH Student Talia Hollzman
Thesis Advisor for MSPH Student Blanca Noriega
Capstone Advisor for MPH Student Jacob Batycki
Present- August 2015
The Learning Collaboratory- Latin America
Thesis Advisor for MSPH Student Johnny Galli
Thesis Advisor for MSPH Student Yoselin Diaz
Thesis Advisor for MSPH Student Xeniamaria Rodriguez
December 2016 - August 2014-
The Learning Collaboratory
Capstone Advisor for MPH Student Monica Bahamon
Capstone Advisor for MPH Student Valerie Daniel
Capstone Advisor for MPH Student Amanda Muana
Capstone Advisor for MPH Student Roxane Williams
Capstone Advisor for MPH Student Cari Eckman
Capstone Advisor for MPH Student Stephanie Maestri
Capstone Advisor for MPH Student Cassandra Rene
Capstone Advisor for MPH Student Nagarjuna Sidhabathuni
Capstone Advisor for MPH Student Ari Urbish
Capstone Advisor for MPH Student Danielle Rodriguez
Capstone Advisor for MPH Student Theta Brown
December 2015- September 2013
Capstone Advisor for MPH Student John Salerno
Capstone Advisor for MPH Student Laurian Walters
Capstone Advisor for MPH Student Krystal Sardinas
Capstone Advisor for MPH Student Leighan Panico
Capstone Advisor for MPH Student Yanel Diaz
Capstone Advisor for MPH Student Alla Alghamendi
Capstone Advisor for MPH Student Lamia Houssain
December 2015- January 2013
Capstone Advisor for MSPH student Angel Maldonado
December 2014- June 2012
Capstone Advisor for MD/ MPH student Rammy Assaf.
Capstone Advisor for MD/ MPH Joanne Duara
Present- May 2012
Capstone Advisor for MPH student Amanda Leipold.
June 2014- September 2013
Capstone Advisor for MPH Andres Von Watcher
June 2014 - May 2013
Capstone Advisor for MPH Irene Kirolos
26
June 2014 -March 2013
Capstone Advisor for MPH Rachel Nomberg
Capstone Advisor for MPH Paula Espinal
Capstone Advisor for MPH Karina Lizzi
December 2013- January 2013
Capstone Advisor for MD/ MPH student Maryann Koussa.
August 2013-January2013
Capstone Advisor for MPH student Larisa Topeka.
August 2013- July 2012
Capstone Advisor for MPH student Vanessa Harrysingh.
June 2012
Capstone Advisor for MPH student Joana Diaz.
December 2012- 2009
Mark Stoutenberg, Ph.D., Research Assistant Professor, Department of
Epidemiology and Public Health. CTN Scholar awardee. Mentoring on
Clinical Trials methods and implementation.
29.c.1.Mentoring of International Researchers
Present- July 2015 Researchers at the Fundación San Carlos de Maipo, as part of the Technology
Transfer for the implementation of the Familias Unidas Program, Santiago de
Chile.
Present- July 2014 Researchers of the Human Research Council in South Africa, in
Implementation Science, as part of the grant Implementing Comprehensive
PMTCT & HIV Prevention for South African Couples –Collaboration for
Implementation Science.
Present – July 2014 Researchers at the Universidad Católica Santiago de Guayaquil as part of the
Technology Transfer for the implementation of the Familias Unidas Program
Ecuador.
Present- March 2011
Researchers of the National Institutes of Psychiatry in Mexico as part of the
grant Technology Transfer for the Implementation of Randomized Clinical
Trials with the NIDA CTN Standards at the National Institutes of Psychiatry in
Mexico. Mentees: Dr Rodrigo Marin Navarrete, Dra Marcela Tiburcio, Dra
Asunción Lara, Dr Ricardo Nani. Principal Investigator in Mexico Dr Maria
Elena Medina Mora. Although the grant is finished, I continue to mentor the
above-mentioned researchers and their students.
July 2012- July 2011
Maria Garcia Anaya, M.D., Ph.D., CTN Invest International Mexican Fellow.
Mentoring on Clinical Trials methods, implementation and transfer of
27
Technology with rigors of NIDA CTN.
June 2010- June 2009
Mario Zapata, Ph.D., CTN Invest Fellow. Mentoring on Clinical Trials methods
and implementation.
30. Thesis and Dissertation Advising/Post-doctoral Student Supervision:
June 2016 Committee Member, "Substance Use and HIV Sexual Risk Behaviors among
Vulnerable Populations: Substance Users, STD Clinic Patients and Hospitalized
HIV-Infected Patients” Yue Pan dissertation defense, University of Miami
VII. Service
31. Academic Service
31.a University of Miami
2016- Present Interim Director of Masters in Public Health Programs, Department of
Public Health Sciences
2011-Present Capstone Committee Member and Advisor for the Department of
Public Health Sciences.
2010- 2013 Member of the Admissions Committee for Miller School of Medicine.
2006- Present Executive Director for the Florida Node for the National Clinical
Trials Network, University of Miami, Miller School of Medicine.
32. Professional Service
2015-2014 Peer review board member for grants submitted to the Canadian Health Research
Institute, for the Canadian Research Initiative on Substance Misuse (CRISM).
2014 Program Chair of the National Conference of the National Hispanic and Latino
Addiction Technology Transfer Center on Integrating Research, Education and
Services to Reduce Behavioral Health Disparities in Hispanic and Latino
Populations, Austin, Texas, October 8th and 9th.
Present-2013 Advisory Member for Latino and Hispanic Addiction Technology Transfer
Center.
Present-2013 Member of the Data Safety Monitoring Board for grant NIDA, R01 DA032723,
Family and Adolescent Motivational Incentives for Leveraging Youth. Michael
Robbins, Principal Investigator.
28
Present-2013 Member of the Data Safety Monitoring Board for NIDA R34 DA031973
Contingency Management for Smoking Cessation in Pregnant Minority Women
Veronica Arcornero, PI.
2013-2011 Member of the Data Safety Monitoring Board for grant NIDA R01 DA025894
“Preventing Drug Abuse and HIV in Hispanic First Offenders.” Guillermo
Prado, PI.
2013-2011 Member of the Data Safety Monitoring Board for grant “Familias Unidas Stage
III Study: Preventing Substance Use and HIV in Hispanic Youth.” Guillermo
Prado, PI.
2011-2010 Co-Chair of the Psychology Interest Group of the National Drug Abuse
Treatment Clinical Trials Network.
2012 Regional Advisory Council, Southern Coast Addiction Technology Transfer
Centers.
2001-1999 Co-Investigator and Study Coordinator of Clinical Trials, Center for Clinical
Research, Department of Psychiatry, Hospital Italiano de Buenos Aires,
Argentina
1996 Organizing Committee Member for the Conference for Residents in Mental
Health for the Buenos Aires Metropolitan Area
32. Community Service:
2014- 2012 Field Trip Sponsor, Pineview Preschools.
2014- 2012 Parent Reading Sessions for Toddlers and Preschoolers, Pineview Preschools.
2010 Coordinated series of day sailing trips for Veterans with PTSD and
Substance Use disorders, in SSV Aventura.